Onaka T, Kato-Ogura A, Otsuka Y, Iwai F, et al. A case report of combined treatment of gilteritinib and LH-RH agonist for Fms-related tyrosine kinase 3 receptor mutation-positive acute myeloid leukemia and bone marrow metastasis of prostate cancer. Ann Hematol 2021 Apr 12. pii: 10.1007/s00277-021-04516.
PMID: 33846854